K042731

Substantially Equivalent

ARCHITECT CA 125 II ASSAY

Applicant: Fujirebio Diagnostics,Inc.
Product code: LTK
Advisory panel: Immunology
Date received: 2004-10-01
Decision date: 2004-11-19
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Malvern, PA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.